You are here

stomach cancer

ALX Oncology Shares Drop 15% Following Positive Phase 2

Yahoo/Guru Focus

Fri, 01/24/25 - 11:26 am

clinical trials

gastroesophageal cancer

Experts support FDA's plan for restrictions on PD-1 drugs in stomach, esophageal cancers

Fierce Pharma

Thu, 09/26/24 - 06:35 pm

PD-1 inhibitors

esophageal cancer

Eli Lilly partner Hutchmed scraps China stomach cancer filing as approval seems unlikely

Fierce Pharma

Fri, 08/30/24 - 11:40 am

FDA weighs limiting PD-1 drugs in stomach cancer, calls on experts to discuss Merck, BMS and BeiGene meds

Fierce Pharma

Fri, 08/23/24 - 10:55 am

Bristol Myers Squibb

After metastatic disease win, Merck's Keytruda flunks trial in early stomach cancer

Fierce Pharma

Tue, 06/20/23 - 09:39 pm

Merck targets BMS' stomach cancer head start with Keytruda win, but past failure casts shadow

Fierce Pharma

Thu, 02/16/23 - 04:54 pm

clinical trials

Deciphera details stomach cancer flop against Pfizer’s Sutent, cracking the door open for off-label use

Fierce Pharma

Tue, 01/25/22 - 11:28 pm

Deciphera Pharma

SeaGen builds cancer drug pipeline with China biotech deal

BioPharma Dive

Mon, 08/9/21 - 11:47 pm

Imugene HER2 vaccine hits target in stomach cancer trial

Pharmaforum

Tue, 07/6/21 - 10:46 am

cancer of the gastro-esophageal junction

clinical trials

Merck to withdraw dangling accelerated approval for Keytruda in third-line stomach cancer

Endpoints

Thu, 07/1/21 - 11:09 pm

Keytruda should lose stomach cancer indication, says ODAC

Pharmaforum

Fri, 04/30/21 - 11:09 am

AZ/Daiichi Sankyo’s Enhertu gets second US cancer indication

Pharmaforum

Mon, 01/18/21 - 01:15 pm

Why Five Prime Therapeutics Stock Gained 312% in November

Motley Fool

Tue, 12/8/20 - 10:46 am

Five Prime Therapeutics

Five Prime looks to turn a corner

EP Vantage

Wed, 11/11/20 - 10:55 am

Five Prime Therapeutics

ASCO data back AZ/Daiichi Sankyo’s Enhertu in new HER2 cancers

Pharmaforum

Sat, 05/30/20 - 08:04 pm

colorectal cancer

Blueprint gets first approval as FDA backs stomach cancer drug

Pharmaforum

Fri, 01/10/20 - 10:20 am

Blueprint Medicines

One of Merck’s pivotal stomach cancer trials for Keytruda flops, just months after an FDA OK

Endpoints

Thu, 12/14/17 - 09:25 pm

clinical trials

Lilly Nixes Expansion of Stomach Cancer Drug After Mixed Study Results

Xconomy

Mon, 12/11/17 - 11:18 pm

Merck's Keytruda resumes regulatory hot streak with stomach cancer approval

Fierce Pharma

Mon, 09/25/17 - 07:28 pm

Bristol-Myers' Opdivo succeeds in key stomach cancer study

Yahoo/Reuters

Thu, 11/10/16 - 11:02 am

Bristol-Myers Squibb

Pages